Steffie Groenland obtained her MD at the VU Medical Centre in Amsterdam, The Netherlands (2016) and trained as a Clinical Pharmacologist at the Netherlands Cancer Institute (2021). She did a PhD on optimizing exposure of oral targeted therapies in oncology at the Netherlands Cancer Institute (2021). Currently, she is working as a resident in Internal Medicine at the Rode Kruis Hospital (Beverwijk) and Amsterdam University Medical Center.
